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10 Institute of Global Health, University of Geneva, Geneva, Switzerland 
 
Brief summary: We used phylogenetics and phylodynamics to classify over 
time HCV infections in HIV-positive MSM as either domestically or 
internationally acquired. We found that while international transmission 
dominated initially and persists, local transmission has established as the 
main source of infections. 
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Abstract 
Background: Scale-up of direct-acting antiviral(DAA) therapy is expected to 
abate HCV incidence among HIV-positive men-who-have-sex-with-
men(MSM). Treatment programs in neighbouring countries may influence 
each other’s outcomes through international transmission. 
We aimed at classifying HCV infections in HIV-positive MSM as either 
domestically or internationally acquired, and at estimating how this 
classification changed over time.  
Methods: HCV subtype 1a (the most frequent subtype among MSM) 
genomes from 99 persons enrolled in the Swiss-HIV-Cohort-Study(SHCS) 
and diagnosed with replicating HCV infections between 1999 and 2016, were 
sequenced. Sixty-six of these sequences were from MSM. We inferred 
maximum-likelihood phylogenetic-trees and time-trees containing a fragment 
of the NS5B region of these and other 374 circulating strains retrieved from 
national and international databases. We inferred transmission clusters 
from these trees and used the country composition of such clusters to 
attribute infections to domestic or international transmission.  
Results: Fifty to 80% of HCV transmissions were classified as domestic 
depending on the classification criterion. Between 2000 and 2007, the 
fraction attributable to domestic transmission was 54%[range:0%-75%]. It 
increased to 85%[range:67%-100%] between 2008 and 2016.  
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Conclusions: International and domestic transmission have played major 
roles in the epidemic. While international transmission persists, local 
transmission has established as the main source of infections. 
Keywords: Men who have sex with men; Hepatitis C virus; HIV; Direct-
acting antivirals; transmission. 
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Introduction 
HIV-positive men who have sex with men (MSM) have become a main 
transmission group for hepatitis C virus (HCV) infection in Switzerland and 
other industrialized countries. Increased HCV transmission among HIV-
positive men who have sex with men started to be reported in the early 
2000’s[1-4]. Molecular epidemiological analyses demonstrated international 
networks of sexual transmission of HCV [5, 6]. The spread of HCV among 
HIV-positive MSM has continued ever since [4, 7-9].  
Rapid scale-up of early direct-acting antiviral (DAA) therapy for HCV is 
ongoing in many European and non-European countries [10, 11] as 
reimbursement restrictions are progressively relieved. Projections from 
mathematical models for several Western countries [12-15] and early 
surveillance data from the Netherlands and Switzerland support the claim 
that DAA scale-up may abate the high incidence of HCV in HIV-positive MSM 
[15-19].  
The relative magnitude of domestic versus international HCV transmission 
could be a key parameter for the success of isolated national treatment 
strategies: national micro-elimination and prevention programs can only be 
successful if a significant fraction of infections are acquired domestically, 
while international coordination becomes more important with frequent 
international transmission. Indirect genetic evidence for Switzerland 
suggests an important  role of domestic transmission [20]. Switzerland is 
ideally placed to study international transmission due to its small population 
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size, the high proportion of MSM followed within the Swiss HIV Cohort Study 
(SHCS; www.shcs.ch) [21], and its connections to international networks of 
sexual transmission [22, 23].  
This study aimed at classifying HCV infections in HIV-positive MSM in 
Switzerland as domestically or internationally acquired, and at estimating 
how this classification changed over time. We did this by locating infections 
in transmission clusters inferred from phylogenetic reconstructions and by 
timing transmission events.  
 
Methods 
This study took place in the SHCS. The SHCS is a nationwide prospective 
cohort that routinely collects clinical and epidemiological data from HIV-
positive persons aged > 18 years since 1988. The SHCS has been approved 
by the ethics committee of the participating centers and written informed 
consent had been obtained from all participants. The prospectively collected 
data comprise behavioural and clinical information as well as laboratory 
measurements including routine HCV antibody screening for incident 
infections and HCV-RNA to detect reinfections. We estimate that more than 
80% of all MSM diagnosed with HIV in Switzerland are followed within the 
cohort network [24] [25]. The prevalence of HCV in HIV-positive MSM in the 
SHCS was 4.8% in June-2016, and the fraction of infections with genotypes 
1, 2, 3 and 4 were 72%, 1%, 5% and 22%, respectively [17]. This molecular 
analysis deals with subtype 1a, the most frequent one in our study 
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population, accounting for 60% of HCV infections. For genome sequencing, 
we included all MSM with HCV subtype 1a replicating infections who had 
available plasma sample for sequencing. We refer to these as “Swiss MSM 
sequences” from now on. 
To enable comparative analyses, we also sequenced additional cohort 
participants (other than MSM) with incident infections, also subject to 
availability of plasma sample from the SHCS biobank.  
 
Sequencing of hepatitis C virus infections: HCV RNA genome sequences 
were generated by amplification of almost full length HCV RNA followed by 
massive parallel sequencing. Viral RNA was extracted from plasma stored in 
the SHCS biobank (www.shcs.ch) by an automated nucleic acid extractor 
(EasyMag, BioMerieux) [26] and Nucleospin RNA Virus Kit (Macherey-Nagel). 
RNA was then amplified by RT-PCR. A MiSeq (Illumina) instrument was 
utilized for sequencing. Finally, a consensus sequence was generated for 
each HCV isolate by iterative sequence alignment against an HCV reference 
sequence with SmaltAlign (MIT). The Hepatitis C Virus isolate H77 (GenBank 
accession number NC_004102) served as reference sequence. Our near full 
length sequencing spanned nucleotides 62 to 9'376 of this reference. To 
allow comparison with international sequences we focused on the 436 base-
pair fragment coding for the C-terminal part of the NS5B region, because 
this segment is relatively abundant in public databases [27] and the basis of 
previous studies on HCV transmission among MSM [5, 8, 9, 27].  
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Maximum likelihood phylogenies: We compared 66 Swiss MSM sequences 
with a set of background sequences, which included 33 derived from 
incident infections in persons enrolled in the SHCS with HIV transmission 
risk other than MSM, 81 from chronic infections in persons enrolled in the 
SHCS and 293 sequences retrieved from public databases [28] using the 
Basic Local Alignment Search Tool (BLAST) [29] to identify relevant 
background sequences by means of similarity criteria with respect to the 
sequences obtained for this study. We used RAxML [30] to infer Maximum 
Likelihood (ML) phylogenetic trees assuming a general time reversible with 
invariant sites (GTRI) model with gamma-distributed substitution rates with 
four categories. One hundred replicates resulted in an estimation of the best 
tree and bootstrap supporting values for each bipartition. Transmission 
Clusters: A subtree with a bootstrap support value >70% was defined as a 
transmission cluster (3 members or more) or a transmission pair (2 
members). We only analyzed transmission clusters or pairs that included 
study sequences because only those are relevant for the study question.  
 
Likely geographic origin of infections: We classified our study sequences 
as corresponding to transmissions likely to have occurred by contact with 
MSM living either in Switzerland or abroad, and termed them domestic or 
international transmissions, respectively. We classified a study sequence as 
corresponding to domestic transmission if it was located in a Swiss 
transmission cluster, and as corresponding to international transmission if 
it was located in an international transmission cluster. A transmission 
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cluster was defined as Swiss when the fraction of its sequences that were 
Swiss equaled or exceeded a given threshold named “Swiss dominance 
criterion”. We studied Swiss dominance criteria ranging between 50% and 
90%.  Likely geographic origin of sequences found to belong to more than 
one cluster was determined based on the most internal cluster they belonged 
to.   
International linkages of the Swiss epidemic: We defined and computed a 
measure of the strength of the linkage between the Swiss epidemic and those 
in other countries whose sequences could be included in our analyses. This 
measure consisted of assigning weights to each region according to its 
frequency of appearance in clusters containing Swiss MSM sequences. We 
defined the measure as follows:     
 
 
∑   
     where    ∑  
 
  is the total 
number of Swiss MSM sequences,   indexes international clusters,    is the 
number of Swiss MSM sequences in cluster  ,    indexes countries of origin 
others than Switzerland, and   
  is the fraction of sequences in the 
international cluster   which country of origin is  .  
Time origin of Swiss clusters: We estimated the origin of Swiss 
transmission clusters identified from the ML phylogenetic tree. These origins 
can be interpreted as proxies for introduction times of HCV into Switzerland, 
which resulted in domestic sub-epidemics.  
For this purpose, we re-inferred Swiss transmission clusters with five or 
more members using BEAST [31], which resulted in time trees for each of 
these clusters. Our estimations of a cluster’s origin corresponded to the 
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heights of such the time trees. BEAST analyses utilized the general time-
reversible substitution model with invariant sites (GTRI) with gamma-
distributed rate variation (in accordance with the ML estimation depicted 
above) and an uncorrelated lognormal relaxed molecular clock model [32]. 
The Birth-Death Skyline Serial model (BDSKY) implemented in BEAST 
provided a surrogate HCV transmission model [33]. Table S1 provides 
further details on the parameterization of this analysis. The results reported 
in this manuscript correspond to runs that reached markov chain 
montecarlo (MCMC) chain lengths of 5 x 107. The minimum effective sample 
sizes (ESS) across estimated parameters was> 800. 
 
Trends in geographic origin of HCV infections: We identified time changes 
in the fraction of infections attributable to domestic (versus international) 
transmission by timing the transmission events associated with our study 
sequences. As proxy for transmission time, we used branching times 
involving our study sequences in a time tree. This time tree was constructed 
using BEAST by the same method as above and included the same set of 
sequences the ML tree did. For this estimation, we only considered 
branching times corresponding to nodes with posterior probabilities >70%. 
BEAST analyses only included sequences with available sampling date. 
 
Sensitivity Analysis: In order to test the robustness of the trends in 
geographic origin of HCV infections, we performed a sensitivity analysis on 
the time-tree. This sensitivity analysis accounted for potential imbalance of 
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sampling rates (Swiss versus international sequences) over time. Such 
imbalance may arise from the fact that while the sampling of international 
sequences slowed down towards the end of the study period, the SHCS 
continued to perform HCV sequencing (see Text S1).  
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Results  
 Sequencing of hepatitis C virus infections: Overall, by means of Illumina 
technology we obtained 99 HCV subtype 1a genomes from persons who were 
diagnosed with HCV infections between 1999 and 2016. Sixty-six were from 
63 MSM (3 reinfections) and constitute our study sequences: “the Swiss 
MSM sequences”. The Swiss MSM sequences account for 66% of infections 
with this genotype diagnosed in MSM enrolled in the SHCS during the study 
period. Table 1 shows the characteristics of the MSM participants. Patients’ 
median age was 45 years [IQR: 41 - 51] and 75% (47/63) ever reported 
inconsistent condom use with occasional partners. Fifty four percent (34/63) 
and 14% (9/63) reported the use of any or intravenous recreational drugs 
respectively. Previous publications have described in detail HIV/HCV co-
infected MSM enrolled in the SHCS [17, 18, 34] Sampling dates of Swiss 
MSM sequences ranged between June-2002 and May-2016. The Swiss MSM 
sequences have been submitted to GenBank, accession numbers are 
MK314737 to MK314802.  
 
Transmission Clusters: Ninety percent (60/66) of the Swiss MSM sequences 
were located within 14 MSM transmission clusters (7 nested, i.e., embedded 
in larger clusters) and 12 transmission pairs (8 nested) (Table 2, Figure 1).  
Within-cluster patristic distance was (mean[range]) 0.27%[0%-0.68%]. This 
value fulfils commonly used criteria for clustering (e.g. 1-10%), and therefore 
provides further support for the adopted cluster definition based on 
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bootstrap values. Only two study sequences clustered or paired with 
sequences from men enrolled in the SHCS who reported intravenous drug 
use as the most likely mode of HIV transmission. Figure 1 displays all 
transmission clusters and pairs containing study sequences; The median 
number of identifiable countries involved in not Swiss-only clusters was 4 
[range 2-9]. Figure S1 shows the full phylogenetic tree.  
The aforementioned transmission clusters were identified as MSM clusters 
based on cohort data in the case of Swiss sequences and by inspection of the 
associated papers in the case of international sequences. Table 2 depicts the 
clusters identified in this analysis.  
Likely geographic origin of infections: Fifty percent (30/60, Figure 1) of 
Swiss MSM sequences were located in cluster C1 consisting predominantly 
of Swiss and German sequences. This cluster contains sub-transmission 
clusters C4, C8 and tree transmission pairs, all consisting only of Swiss 
sequences and including 13 Swiss MSM sequences in total. Eighteen percent 
of study sequences (11/60) were located in cluster C2 consisting 
predominantly of Swiss and British sequences. The Swiss part of this cluster 
is a Swiss-only subtree, but the bootstrap support value for this subtree 
(60%) does not fulfil the criteria for a transmission cluster as defined for this 
study. Three sequences could not be linked to any transmission cluster. 
Overall, 50% (33/66) of Swiss MSM sequences were located in Swiss only 
clusters or transmission pairs. 
Panel A of Figure 2 shows the fractions of study sequences classified as 
domestic, international and unknown transmission for a range of Swiss 
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dominance criteria (minimum percentage of sequences in the clusters that 
are required to classify a cluster as Swiss). When this criterion was set to 
50% or 60%, 80% and 79% of sequences were classified as domestic 
transmission respectively. When the criterion was raised to 90%, half of the 
sequences were classified as domestic transmission.  
International linkages of the Swiss epidemic: Panel B of Figure 2 shows a 
measure of the strength of the linkage between the HCV epidemic in 
Switzerland and those in other countries as suggested by the ML 
phylogenetic tree. This measure suggests that the Swiss epidemic is closely 
linked to those in the UK, The Netherlands and Germany.  
Time origin of Swiss clusters: We next investigated the time origin of the 
best-supported Swiss dominated clusters. For these estimates, monophyletic 
trees containing five or more members and fulfilling a Swiss dominance 
criterion of 80% (see Table 2) defined a best-supported Swiss cluster. 
Phylodynamic re-inference of these clusters estimated that their origins 
ranged between (median) October-1999 and June-2007 (Table 2; 
Supplementary Figure S2).  
Trends in geographic origin of HCV infections: The time tree constructed 
including all sequences with available sampling dates suggests that until 
2004 most transmissions occurred by contact with MSM not living in 
Switzerland (Figure 3). Of note, none of MSM whose transmissions were 
estimated to have occurred before 2002 ever reported drug injection. Neither 
did they cluster with Swiss sequences from persons reporting drug injection. 
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Between 2000 and 2007, the fraction attributable to domestic transmission 
was 54%[range: 0%-75%]. It increased to 85%[range: 67%-100%] from 2008 
to the end of the study period (Figure 3).  
Sensitivity Analysis: The sensitivity analysis (Figure S3) supports the 
observation, derived from Figure 3: that the contribution of domestic 
transmission increased over time. Figure S3 suggests that changing 
sampling rates do not explain the increasing trend in domestic transmission 
displayed in Figure 3. The simulated fraction attributable to domestic 
transmission (for 80% dominance criterion) increased from 25% (95%CI: 
11%-25%) between 2000 and 2007 to 82% (51%-85%) between 2008 and 
2016 (versus 54% and 85% for the same time periods in the main analysis). 
These results suggest that our main findings were robust to variations in 
sampling density. 
 
Discussion  
This molecular epidemiology study suggests that both Swiss-domestic and 
international HCV transmission contribute substantially to the HCV 
epidemic among HIV-positive MSM in Switzerland. The relative contribution 
of international transmission declined with time, and gave place to domestic 
transmission as the major source of infections. We found no significant trace 
of transmission bridging from persons who became infected with HIV 
through drug injection and MSM within Switzerland, suggesting that the 
HCV epidemics in these two HIV transmission groups are likely 
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disconnected. This is in line with a former phylogenetic study of HIV 
transmission in Switzerland were only 2% of HIV sequences from persons 
who inject drugs clustered with those from MSM [23]. Due to lack of 
behavioural data on concurrence of sexual practices associated with HCV 
transmission and the use of intravenous drugs [35, 36], our study could not 
assess frequencies of HCV transmission routes (i.e., traumatic sex versus 
intravenous drug use). 
Our analyses suggest that the initial cases of sexually transmitted HCV in 
MSM in Switzerland are mainly attributable to international transmissions 
among MSM, and not to spillovers between persons who inject drugs and 
MSM within Switzerland. Swiss-domestic HCV transmission among MSM 
has grown over time. This implies that intensive test-and-treat interventions 
at the national level are likely to succeed. This notion is supported by data 
from Switzerland, where the Swiss HCVree Trial, a test-treat-and-counsel 
study [14, 16-18] has been followed by a decline in the number of cases of 
acute HCV infections among MSM in the SHCS. Importantly, early data from 
the Netherlands also indicates declines in incident cases in this population 
after introdu tion of universal access to DAA therapy [10]. Our finding of 
persistent international transmissions may imply that coordinated HCV 
treatment scale-up in different countries could amplify the decrease in HCV 
transmissions. 
The estimated time origins of Swiss transmission clusters can be interpreted 
as illustrations of critical time-points when treatment and/or behavioural 
interventions could have had prevented new transmission chains. We 
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estimated origins of Swiss clusters ranging between 1999 and 2007, which 
overlaps with a sharp rise in HCV incidence among HIV-positive MSM in 
Switzerland [34]. This may have occurred, at least partially, due to such 
introduced cases spreading in Switzerland. 
Limitations: This analysis relies on public databases to obtain background 
international sequences. While a large number of those were included, the 
fact that European countries may be unevenly represented in Genbank, is a 
limitation of this study. Our estimations on linkages of the Swiss epidemic to 
specific countries were therefore likely biased. The segment of the HCV 
genome we chose for these analyses was the one that resulted in the most 
suitable set of background sequences, in particular because it has been the 
basis of other phylogenetic analyses across Europe [5, 37]. However, 
countries such as France and Italy were likely under-represented in our 
analyses (only 8 and 3 sequences respectively were included). Evener 
sampling rates across geographic regions as well as increasing sequencing of 
longer regions of the HCV genome, should improve estimates of transmission 
patterns in the future [38]. 
The fact that the number of international HCV sequences available from 
public databases declined towards the end of the study period, is also a 
potential limitation of this study. It could potentially have led to 
overestimations of the contribution of domestic transmission towards the 
end of the study period. However, the contribution of domestic transmission 
started to increase early on, before the aforementioned disparity could have 
had any effect. Moreover, the estimated time trend in domestic versus 
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international transmission held true when confronted with a sensitivity 
analysis that assumed a set of hypothetical international sequences 
iteratively attaching to the transmission clusters, which deliberately 
decreased the likelihood of domestic transmission. Finally, potential under-
reporting of intravenous drug injection may have prevented us from 
recognizing more transmission bridges between MSM and persons who inject 
drugs. 
 
To our knowledge, this is the first study to quantify the contribution over 
time of international transmission to a national HCV epidemic in MSM. We 
did this by combining phylogenetic and phylodynamic analyses of a 
representative sample of HCV genome sequences from infections observed in 
Switzerland. 
Previous studies have demonstrated the emergence of epidemics of HCV 
transmitted through sexual practices and depicted its separation from 
transmission networks formed by persons who inject drugs [5, 37]. These 
molecular epidemiological studies revealed international networks of HCV 
transmission among HIV-positive MSM. Our study evidences high levels and 
increases of domestic transmission within Switzerland. It also indicates that 
the contribution of international HCV transmission networks persists 
although its importance declined over time. 
 
Implications of findings: 
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Previous modelling studies and empiric data indicate that DAA scale-up has 
the potential to curb the HCV epidemic among HIV-positive MSM [12-15]. 
Our results suggest that for a successful treatment-as-prevention approach 
and a correct interpretation of its effects, international transmission should 
be considered; and that targeted joint European scale-up schemes may 
increase the efficiency of such interventions.  
Time-updated HCV phylogenies for Europe could help monitoring the impact 
of national DAA scale-up programs, and they would allow measuring the 
effect of treatment-as-prevention on large-scale transmission networks. This 
requires international coordination to sequence the same or overlapping 
regions of the HCV genome. 
Conclusion 
This molecular epidemiological study suggests that both international and 
local transmission have played major roles in the Swiss epidemic of hepatitis 
C among HIV-positive MSM, and that, while international transmission 
persists, Swiss domestic transmission has gained importance over time.   
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Figure legends 
Figure 1. Phylogenetic tree showing the clusters that contain the study 
sequences (Swiss MSM sequences). Clusters were defined as monophyletic 
trees with >70% bootstrap support value. The full tree (from which this one is 
derived Figure S1) was computed using RAxML with 100 replicates and a general 
time reversible model with invariant sites (GTRI) and gamma-distributed 
substitution rates.  
Figure 2. Likely geographic origin of infection (A) and international 
linkages of the Swiss MSM sequences (B). This classification was derived 
from the clusters identified in the ML phylogenetic tree.  
Swiss dominance criteria: minimum percentage of sequences in the clusters 
that are Swiss necessary to classify a cluster as Swiss. 
 
Figure 3. Time trends in the fraction of HCV infections attributable to 
domestic and international transmission. This classification assumed an 
80% dominance criteria and was derived from the time tree inferred using 
BEAST 2.0. Branching times involving our study sequences (Swiss MSM 
sequences) served as proxy for transmission times. 
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Figure 1 
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Figure 2 
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Figure 3 
 
  
D
ow
nloaded from
 https://academ
ic.oup.com
/jid/advance-article-abstract/doi/10.1093/infdis/jiz069/5318573 by E-Library Insel user on 19 February 2019
Ac
ce
pt
ed
 M
an
us
cr
ipt
 
32 
 
Table 1. Characteristics of men who have sex with men included in the 
study. Sixty-six sequences (including three reinfections) were obtained from 
63 men who have sex with men. 
Number of patients 63 
Age at sampling time (years, median[IQR]) 
45 [41 - 
51] 
ART ever started (N [%]) 62 [94] 
Drug use during follow-up   
                 Ever - all modes of administration (N [%]) 34 [54] 
                 Ever - intravenous (N [%]) 9 [14] 
Sex with occasional partners   
                                                   Ever 63 [100] 
Condom use with ocassional partners   
Consistent 12 [19] 
Inconsistent 47 [75] 
Refuse to answer 0 
Missing 4 [6] 
Ethnicity   
Caucasian 55 [87] 
Education*   
Lower 6 [10] 
Intermediate 44 [70] 
High 11 [17] 
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Unknown 2 [3] 
*Lower: Mandatory school or lower; High: University    
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Table 2. Description of transmission clusters in Figure 1 and estimated 
origin. The order of cluster indices reflects the number of studied sequences 
located in the respective cluster; "Swissness" refers to the fraction of 
sequences of Swiss origin in the cluster. The table reports time of origin for 
clusters with five or more members and swissness equal or larger than 80%. 
Time trees are shown in Figure S2. 
     
Primary Nested Size 
Study 
sequences 
(n)  
Swissness 
Estimated 
time 
origin 
C1   52 30 65% - 
  C4 6 4 100% Jun 2007 
  C8 3 3 100% - 
C2   33 11 33% - 
  C3 27 11 41% - 
C5   19 4 21% - 
  C6 18 4 22% - 
  C9 17 3 18% - 
  C12 3 1 33% - 
C7   5 4 80% Nov 2000 
  C10 3 3 100% - 
C11   6 3 100% Oct 1999 
C13   11 1 9% - 
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C14   36 1 14% - 
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